ZI Price Prediction Next Week
Analysis and Insights
Technical Analysis:
ZoomInfo Technologies Inc (ZI) has shown recent bullish momentum, crossing above its 200-day moving average (DMA) at $10.85, a positive technical signal. The stock closed at $11.065 on March 24, 2025, with a pre-market gain of 1.93%. Key technical indicators include:
- RSI (14): 51.86, indicating a neutral position.
- MACD: A slight positive signal with a value of 0.04.
- Fibonacci Levels: Pivot at $10.85, with resistance levels at $11.33 (R1) and $11.62 (R2).
News and Fundamental Analysis:
ZoomInfo recently reported strong Q4 2024 earnings, beating analyst estimates with adjusted EPS of $0.26 (vs. $0.22 expected) and revenue of $309.1M (vs. $297.64M expected). Despite a 2% YoY revenue decline, the company showed operational improvements, including a 35% operating margin and $562.3M in stock buybacks. Management guidance for Q1 2025 was conservative but positive, with expected revenue of $294-$297M.
Analysts have responded positively, with price target increases from firms like Canaccord Genuity (to $15) and Piper Sandler (to $11). The stock surged 24.9% post-earnings, reflecting improved sentiment.
Conclusion:
Based on technical indicators and positive earnings momentum, ZI is expected to rise next week. The stock is likely to test resistance at $11.33 and $11.62. Predicted price: $11.50. Recommendation: Buy.
ZI Similar Chart Price Prediction
The price of ZI is predicted to go up -4.97%, based on the high correlation periods with VVX. The similarity of these two price pattern on the periods is 95.98%.
ZI
VVX
Down: -4.97%Similarity: 95.98%
ZI Revenue Forecast
ZI EPS Forecast
ZI FAQs
What is ZI revenue forecast for next quarter？
What is ZI eps forecast for next quarter？
ZI Analyst's Forecast
David Hynes
Canaccord Genuity
Strong Buy
2025-02-26
Price Target
$14 → $15
Upside
+27.88%
Canaccord raised the firm's price target on ZoomInfo to $15 from $14 and keeps a Buy rating on the shares. The firm said ZoomInfo's Q4 results were another step in the right direction. Both revenue and adjusted operating income topped the high-end of guidance, calculated billings grew by 4% (cRPO- based bookings were flat, the first quarter in six without year-over-year declines), and net new customer additions in the firm's $100K+ cohort grew by 58, which compares to 12 in Q3 and a decline of 49 a year ago.
Elizabeth Porter
Morgan Stanley
Hold
2025-02-26
Price Target
$11 → $13
Upside
+10.83%
Michael Turrin
Wells Fargo
Hold
2025-02-26
Price Target
$11 → $12
Upside
+2.3%
